Asian biopharmaceutical firms, key source of R&D pipeline

Asian biopharmaceutical firms will become key players in the global bioindustry arena as they have well trained researchers with their governments' full support in finance, according to LG Life Sciences President Kim In-chul, who took part in BioMedical Asia 2008, taking place 14 - 17 April 2008 in Singapore.

In his key note, Kim said that hybrid R&D approaches, such as biosimilar drugs and ...